fingolimod hydrochloride has been researched along with TDP-43 Proteinopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gotoh, Y; Jantrapirom, S; Lo Piccolo, L; Nimlamool, W; Potikanond, S; Prachayasittikul, V; Umegawachi, T; Yamaguchi, M; Yeewa, R; Yoshida, H | 1 |
1 other study(ies) available for fingolimod hydrochloride and TDP-43 Proteinopathies
| Article | Year |
|---|---|
A Novel Drosophila-based Drug Repurposing Platform Identified Fingolimod As a Potential Therapeutic for TDP-43 Proteinopathy.
Topics: Amyotrophic Lateral Sclerosis; Animals; DNA-Binding Proteins; Drosophila; Drug Repositioning; Fingolimod Hydrochloride; TDP-43 Proteinopathies | 2023 |